Aerie Pharmaceuticals announced the appointment of Tad Heitmann as Head of Communications, reporting to Judith Robertson, Aerie’s Chief Commercial Officer. Mr. Heitmann will head Aerie’s corporate, commercial, and internal communications activities. He previously held leadership positions at BioComm Network, and Sam Brown Healthcare Communications.
In connection with his acceptance of the position as Head of Communications, Mr. Heitmann will receive awards totaling 14,400 stock options. The stock options will vest over 4 years, with 25% vesting on the first anniversary of the hire date and the remainder vesting ratably on each of the subsequent 36 monthly anniversaries of the hire date. This award was made outside of Aerie’s stockholder-approved equity incentive plan and was approved by the company’s independent directors as an inducement material to Mr. Heitmann entering into employment with the company in reliance on NASDAQ Listing Rule 5635(c)(4), which requires this public announcement.